The
SerOptix process involves the capture of an emitted fluorescence
spectra, with the pattern of emission assessed by analysis of
specified spectral parameters. The spectral readings of blood
samples are compared to models of infected and normal plasma and
quickly identified as diseased or healthy.
Discrimination
Between HCV-Positive and Normal Human Plasma
by Measurement of Intrinsic Fluorescence
(HCV/ID-LBS Assay)
